Recent progress in Helicobacter pylori treatment.

Area of Science:

• Gastroenterology
• Microbiology
• Infectious Diseases

Background:

• Antibiotic resistance is a major challenge in treating Helicobacter pylori infections, impacting treatment efficacy.
• Helicobacter pylori eradication is crucial for preventing associated gastric diseases.
• Developing effective treatment strategies is essential due to rising resistance rates.

Purpose of the Study:

• To review recent advancements in Helicobacter pylori treatment strategies.
• To evaluate the effectiveness of current and emerging eradication regimens.
• To highlight the need for novel approaches to combat antibiotic-resistant H. pylori.

Main Methods:

• Literature review of recent studies on H. pylori treatment.
• Analysis of the efficacy of various eradication regimens, including quadruple therapy, dual therapy, and adjuvant therapies.
• Discussion of the role of antibiotic resistance in treatment selection.

Main Results:

• Bismuth-containing quadruple therapy is effective, particularly against antibiotic-resistant H. pylori strains.
• High-dose proton-pump inhibitor-amoxicillin dual therapy offers a promising alternative, potentially reducing antibiotic overuse.
• Adjuvant therapies (probiotics, vitamins) show potential but require further investigation.

Conclusions:

• Current treatment regimens face challenges due to increasing antibiotic resistance in H. pylori.
• Bismuth-based therapies and high-dose dual therapy are viable options for H. pylori eradication.
• Further research is needed to develop novel drugs and establish comprehensive H. pylori databases for real-time management insights.